Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.6% |
| 2 | Financials | 14.73% |
| 3 | Healthcare | 12.36% |
| 4 | Industrials | 10.02% |
| 5 | Consumer Discretionary | 9.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3301
Nice
NICE
$5.78B
| $730K | ﹤0.01% |
10,606
+589
| +6% | +$39.3K |
|
|
JAX
3302
DELISTED
J. Alexander's Holdings, Inc.
JAX
| $722K | ﹤0.01% |
67,212
+19,808
| +42% | +$196K |
|
3303
ALPS REIT Dividend Dogs ETF
RDOG
$11.3M
| $719K | ﹤0.01% |
17,261
| – | – |
|
3304
VEON
VEON
$3.92B
| $715K | ﹤0.01% |
7,422
+1,353
| +22% | +$117K |
|
|
ICD
3305
DELISTED
Independence Contract Drilling, Inc.
ICD
| $715K | ﹤0.01% |
5,337
+1,012
| +23% | +$113K |
|
|
PFNX
3306
DELISTED
Pfenex Inc.
PFNX
| $713K | ﹤0.01% |
78,659
+11,878
| +18% | +$108K |
|
|
ANDX
3307
DELISTED
Andeavor Logistics LP
ANDX
| $710K | ﹤0.01% |
13,968
-306
| -2% | -$14.5K |
|
3308
Southern Missouri Bancorp
SMBC
$853M
| $707K | ﹤0.01% |
19,982
+8,539
| +75% | +$243K |
|
3309
MediciNova
MNOV
$65.5M
| $704K | ﹤0.01% |
116,655
+290
| +0.2% | +$2.04K |
|
|
MODN
3310
DELISTED
MODEL N, INC.
MODN
| $704K | ﹤0.01% |
79,578
-769
| -1% | -$7.15K |
|
3311
Clear Channel Outdoor Holdings
CCO
$1.23B
| $699K | ﹤0.01% |
138,408
+8,784
| +7% | +$49K |
|
3312
Lennar Class B
LEN.B
$20.1B
| $697K | ﹤0.01% |
21,705
-11,177
| -34% | -$356K |
|
3313
CALL
Aflac
AFL
$60.5B
| $696K | ﹤0.01% |
+20,000
| New | +$704K |
|
|
FOGO
3314
DELISTED
Fogo de Chao, Inc. Common Stock
FOGO
| $696K | ﹤0.01% |
48,468
-191,697
| -80% | -$2.47M |
|
|
STML
3315
DELISTED
Stemline Therapeutics, Inc.
STML
| $685K | ﹤0.01% |
64,014
+14,281
| +29% | +$173K |
|
3316
WisdomTree True Developed International Fund
DOL
$848M
| $680K | ﹤0.01% |
15,884
-3,614
| -19% | -$154K |
|
|
JCAP
3317
DELISTED
Jernigan Capital, Inc.
JCAP
| $680K | ﹤0.01% |
+32,310
| New | +$617K |
|
|
DVAX
3318
DELISTED
Dynavax Technologies
DVAX
| $673K | ﹤0.01% |
170,373
+3,066
| +2% | +$22.5K |
|
3319
Editas Medicine
EDIT
$432M
| $672K | ﹤0.01% |
41,429
+2,878
| +7% | +$43.7K |
|
3320
Chemung Financial Corp
CHMG
$401M
| $666K | ﹤0.01% |
18,313
+9,047
| +98% | +$285K |
|
3321
Ameresco
AMRC
$1.47B
| $662K | ﹤0.01% |
120,416
+10,614
| +10% | +$59K |
|
|
EGIO
3322
DELISTED
Edgio, Inc. Common Stock
EGIO
| $662K | ﹤0.01% |
6,567
+1,085
| +20% | +$92K |
|
3323
WisdomTree US AI Enhanced Value Fund
AIVL
$438M
| $661K | ﹤0.01% |
8,228
-2,434
| -23% | -$192K |
|
3324
Tilly's
TLYS
$121M
| $660K | ﹤0.01% |
50,042
+12,357
| +33% | +$138K |
|
3325
Equity Bancshares
EQBK
$1.06B
| $659K | ﹤0.01% |
19,607
+8,371
| +75% | +$250K |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.